BN Business News
Add your company to Business Communicator →

Business · 01/05/2014Updated: 10/17/2026 · 1 min read

FDA Proposes Changes to Surgical Mesh and Instrumentation for Urogynecologic Procedures

The FDA is proposing to reclassify surgical mesh for transvaginal pelvic organ prolapse repair and urogynecologic surgical mesh instrumentation from class II to class III, and class I to class II, respectively, citing concerns over safety and effectiveness.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →